Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillermo Garcia

Showing results (21-30 of 1,188) with videos related to

Pageof 119
Sort By:
Transplantation|December 20, 2014
Chronic kidney disease in disadvantaged populationsGuillermo Garcia-Garcia, Vivekanand Jha,
Cancer Investigation|February 9, 2008
Treatment strategies in myelodysplastic syndromesEhab Atallah, Guillermo Garcia-Manero
Kidney International|January 31, 2015
CKD in disadvantaged populationsGuillermo Garcia-Garcia, Vivekanand Jha,
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2011
Hypomethylating agents and other novel strategies in myelodysplastic syndromesGuillermo Garcia-Manero, Pierre Fenaux
Pediatric Nephrology (Berlin, Germany)|November 15, 2014
Chronic kidney disease in disadvantaged populationsGuillermo Garcia-Garcia, Vivekanand Jha,
Clinical Advances in Hematology & Oncology : H&O|August 8, 2007
Use of hypomethylating agents in myelodysplastic syndromesEhab Atallah, Guillermo Garcia-Manero
Nature Reviews. Nephrology|January 29, 2015
Nephrology in the developing world. Chronic kidney disease in disadvantaged populationsGuillermo Garcia-Garcia, Vivekanand Jha
Clinical Nephrology|February 17, 2015
CKD in disadvantaged populationsGuillermo Garcia-Garcia, Vivekanand Jha,
Seminars in Hematology|July 15, 2005
Future directions for the use of hypomethylating agentsGuillermo Garcia-Manero, Steven D Gore
American Journal of Hematology|December 8, 2017
Myelodysplastic syndromes: 2018 update on diagnosis, risk-stratification and managementGuillermo Montalban-Bravo, Guillermo Garcia-Manero
Pageof 119

Showing results (21-30 of 1,188) with videos related to

Sort By:
Pageof 119
Transplantation|December 20, 2014
Chronic kidney disease in disadvantaged populationsGuillermo Garcia-Garcia, Vivekanand Jha,
Cancer Investigation|February 9, 2008
Treatment strategies in myelodysplastic syndromesEhab Atallah, Guillermo Garcia-Manero
Kidney International|January 31, 2015
CKD in disadvantaged populationsGuillermo Garcia-Garcia, Vivekanand Jha,
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2011
Hypomethylating agents and other novel strategies in myelodysplastic syndromesGuillermo Garcia-Manero, Pierre Fenaux
Pediatric Nephrology (Berlin, Germany)|November 15, 2014
Chronic kidney disease in disadvantaged populationsGuillermo Garcia-Garcia, Vivekanand Jha,
Clinical Advances in Hematology & Oncology : H&O|August 8, 2007
Use of hypomethylating agents in myelodysplastic syndromesEhab Atallah, Guillermo Garcia-Manero
Nature Reviews. Nephrology|January 29, 2015
Nephrology in the developing world. Chronic kidney disease in disadvantaged populationsGuillermo Garcia-Garcia, Vivekanand Jha
Clinical Nephrology|February 17, 2015
CKD in disadvantaged populationsGuillermo Garcia-Garcia, Vivekanand Jha,
Seminars in Hematology|July 15, 2005
Future directions for the use of hypomethylating agentsGuillermo Garcia-Manero, Steven D Gore
American Journal of Hematology|December 8, 2017
Myelodysplastic syndromes: 2018 update on diagnosis, risk-stratification and managementGuillermo Montalban-Bravo, Guillermo Garcia-Manero
Pageof 119